Platforma

Platforma is the discovery decision platform for biologics. It helps discovery teams turn complex sequencing, experimental, structural, and AI-derived data into transparent, evidence-based decisions about which therapeutic candidates to advance.

Built on MiXCR, the most widely used tool for immune repertoire profiling, Platforma brings every relevant biological signal into a single, reproducible decision framework for:

In vitro antibody discovery — deconvolute phage and yeast display libraries, track enrichment across panning rounds, and separate true binders from fast-growing passenger clones.

In vivo antibody discovery — resolve native heavy/light chain pairings, trace somatic hypermutation to germline, and integrate bulk, single-cell, and multiomics data into one decision matrix.

Peptide discovery, translational immune research & multiomics - Integrate diverse biological datasets—including peptide screening, immune repertoire, single-cell, and multiomic data—into one transparent, evidence-based frame

Advantages

• End-to-end coverage: Bring every relevant signal together in one evidence-based framework for choosing which candidates advance
• Evidence-based candidate prioritization: Move beyond frequency-based selection and isolated metrics to identify diverse, developable, high-potential leads.
• AI-powered discovery decisions: Make complex decisions accessible
• A platform that adapts to your biology: Support any modality, molecular format, or experimental design without rebuilding custom pipelines.
• Decisions you can trust and defend: Transparent rankings, reproducible logic, and explainable evidence behind every candidate selection